SCHEMBL2866332

SCHEMBL2866332

O=C(O)c1coc(Oc2cccc(Br)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.45
CYP1A2 P05177 3/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
RECQL P46063 1/20 0.44
KLKB1 P03952 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.40
KMT2A Q03164 3/20 0.40
ABCG2 Q9UNQ0 1/20 0.39
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873881 0.83 P2RX3 (0.42) CYP1A2KLKB1MRGPRX4CYP2C9CYP2C19
SCHEMBL2638065 0.83 KLKB1 (0.42) MCL1KLKB1ALDH1A1KDM4ECYP2C9
SCHEMBL2880398 0.81 MCL1 (0.46) MCL1KLKB1KMT2AALDH1A1KDM4E
SCHEMBL1660196 0.80 PTGS1 (0.45) KLKB1KMT2AALDH1A1KDM4ELMNA
SCHEMBL2638952 0.80 MAPT (0.50) CYP1A2MAPTGAARECQLMRGPRX4
SCHEMBL2873902 0.80 HAO1 (0.50) KLKB1AKR1C3
SCHEMBL2866370 0.80 KLKB1 (0.40) KLKB1AKR1C3
SCHEMBL1661912 0.80 KLKB1 (0.42) MAPTKLKB1CYP2C9CYP2C19LMNA
SCHEMBL1660164 0.80 KLKB1 (0.44) GAAKLKB1KMT2AALDH1A1KDM4E
SCHEMBL1661148 0.79 MGLL (0.39) KLKB1MRGPRX4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed